← Back to Screener
Heartflow, Inc. Common Stock (HTFL)
Price$31.38
Favorite Metrics
Price vs S&P 500 (26W)-15.11%
Price vs S&P 500 (4W)10.95%
Market Capitalization$2.69B
All Metrics
Book Value / Share (Quarterly)$3.53
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.69
Price vs S&P 500 (YTD)3.37%
Gross Margin (TTM)76.80%
Net Profit Margin (TTM)-66.35%
EPS (TTM)$-1.84
10-Day Avg Trading Volume1.07M
EPS Excl Extra (TTM)$-1.84
EPS (Annual)$-3.17
ROI (Annual)-38.85%
Gross Margin (Annual)76.80%
Cash / Share (Quarterly)$2.07
Revenue Growth QoQ (YoY)-60.95%
ROA (Last FY)-32.49%
EBITD / Share (TTM)$-0.88
Operating Margin (TTM)-40.01%
Cash Flow / Share (Annual)$-0.69
P/B Ratio8.94x
P/B Ratio (Quarterly)8.26x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-1.53x
ROA (TTM)-43.76%
EPS Incl Extra (Annual)$-3.17
Current Ratio (Annual)5.20x
Quick Ratio (Quarterly)4.87x
3-Month Avg Trading Volume1.35M
Revenue / Employee (TTM)$0
P/S Ratio (Annual)15.27x
Asset Turnover (Annual)0.49x
52-Week High$41.22
EPS Excl Extra (Annual)$-3.17
26-Week Price Return-6.36%
Quick Ratio (Annual)4.87x
13-Week Price Return-10.41%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.20x
Enterprise Value$2,642.872
Asset Turnover (TTM)0.66x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-66.39%
Cash / Share (Annual)$2.07
3-Month Return Std Dev80.43%
Net Income / Employee (TTM)$-0
ROE (Last FY)-38.85%
Net Interest Coverage (Annual)-1.12x
EPS Basic Excl Extra (Annual)$-3.17
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.84
P/S Ratio (TTM)15.27x
Revenue / Share (Annual)$4.78
Year-to-Date Return7.51%
5-Day Price Return14.25%
EPS Normalized (Annual)$-3.17
Net Profit Margin (Annual)-66.35%
Month-to-Date Return28.81%
EBITD / Share (Annual)$-1.77
Operating Margin (Annual)-40.01%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-1.84
P/B Ratio (Annual)8.26x
Pretax Margin (TTM)-66.39%
Book Value / Share (Annual)$3.53
Price vs S&P 500 (13W)-13.27%
Beta2.41x
Revenue / Share (TTM)$2.06
52-Week Low$20.13
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.09
4.08
4.08
4.08
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
HTFLHeartflow, Inc. Common Stock | 15.27x | — | 76.80% | -40.01% | $31.38 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
HeartFlow Inc develops AI-powered software solutions for non-invasive diagnosis and management of coronary artery disease. The company operates through a single business segment focused on digital cardiovascular diagnostics. With strong revenue concentration in the United States, HeartFlow also serves markets in the United Kingdom, Japan, and Europe.